Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
778.62
895.02
786.77
827.47
732.60
738.22
742.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
778.62
895.02
786.77
827.47
732.60
738.22
742.38
Raw Material Cost
199.48
280.56
144.93
154.94
151.56
145.79
193.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.96
2.78
2.58
2.68
2.86
2.58
2.97
Selling and Distribution Expenses
249.98
322.21
268.42
209.72
191.40
280.80
209.96
Other Expenses
16.38
18.96
18.59
15.86
15.59
17.09
18.19
Total Expenditure (Excl Depreciation)
628.26
795.17
601.86
525.97
501.69
600.10
588.32
Operating Profit (PBDIT) excl Other Income
150.39999999999998
99.80000000000001
184.89999999999998
301.5
230.9
138.1
154.1
Other Income
14.11
-0.22
12.31
23.11
27.00
19.58
26.88
Operating Profit (PBDIT)
180.88
120.06
215.70
343.18
279.98
181.30
199.94
Interest
14.96
2.78
2.58
2.68
2.86
2.58
2.97
Exceptional Items
-8.31
-124.00
-220.96
-24.07
-16.96
14.52
-43.52
Gross Profit (PBDT)
579.14
614.46
641.84
672.54
581.04
592.43
548.91
Depreciation
16.41
20.44
18.49
18.56
22.07
23.61
19.01
Profit Before Tax
141.20
-27.15
-26.32
297.87
238.09
169.64
134.44
Tax
35.68
19.42
4.42
57.34
52.40
44.70
28.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.53
-46.57
-30.74
240.53
185.69
124.94
106.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.53
-46.57
-30.74
240.53
185.69
124.94
106.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
105.53
-46.57
-30.74
240.53
185.69
124.94
106.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,212.11
6,087.00
6,056.71
6,027.11
5,793.46
5,657.99
5,413.40
Earnings per share (EPS)
0.54
-0.24
-0.16
1.23
0.95
0.64
0.55
Diluted Earnings per share
0.54
-0.24
-0.16
1.23
0.95
0.64
0.55
Operating Profit Margin (Excl OI)
19.31%
11.16%
23.5%
36.44%
31.52%
18.71%
20.75%
Gross Profit Margin
20.24%
-0.75%
-1.0%
38.24%
35.51%
26.18%
20.67%
PAT Margin
13.55%
-5.2%
-3.91%
29.07%
25.35%
16.92%
14.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -13.01% vs 13.75% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 326.39% vs -51.79% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 38.65% vs -40.86% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 435.71% vs 7.69% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of BioMarin Pharmaceutical, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
778.62
1,091.00
-312.38
-28.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
778.62
1,091.00
-312.38
-28.63%
Raw Material Cost
199.48
370.00
-170.52
-46.09%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.96
24.00
-9.04
-37.67%
Selling and Distribution Expenses
249.98
287.00
-37.02
-12.90%
Other Expenses
16.38
21.60
-5.22
-24.17%
Total Expenditure (Excl Depreciation)
628.26
897.00
-268.74
-29.96%
Operating Profit (PBDIT) excl Other Income
150.36
194.00
-43.64
-22.49%
Other Income
14.11
29.00
-14.89
-51.34%
Operating Profit (PBDIT)
180.88
292.00
-111.12
-38.05%
Interest
14.96
24.00
-9.04
-37.67%
Exceptional Items
-8.31
-42.00
33.69
80.21%
Gross Profit (PBDT)
579.14
721.00
-141.86
-19.68%
Depreciation
16.41
69.00
-52.59
-76.22%
Profit Before Tax
141.20
157.00
-15.80
-10.06%
Tax
35.68
23.00
12.68
55.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
105.53
134.00
-28.47
-21.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.53
134.00
-28.47
-21.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
105.53
134.00
-28.47
-21.25%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,212.11
2,676.00
3,536.11
132.14%
Earnings per share (EPS)
0.54
0.87
-0.33
-37.93%
Diluted Earnings per share
0.54
0.87
-0.33
-37.93%
Operating Profit Margin (Excl OI)
19.31%
17.78%
0.00
1.53%
Gross Profit Margin
20.24%
20.71%
0.00
-0.47%
PAT Margin
13.55%
12.28%
0.00
1.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 77.86 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -13.01% vs 13.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6.28% vs 12.71% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.55 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 326.39% vs -51.79% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -43.19% vs 109.36% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.68 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 38.65% vs -40.86% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -34.07% vs 136.67% in Mar 2025
Quarterly - Interest
Interest 1.50 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 435.71% vs 7.69% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 417.24% vs -17.14% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.31%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
